Skip to content
DeepViews

Dolby Laboratories, Inc.Class A (DLB) — Analysis Summary

Dolby Laboratories, Inc.Class A (DLB) has a market cap of $5.44B with year-over-year revenue growth of +5.9%. Net margin stands at 18.9%. The stock trades at a P/E ratio of 24.0.

Key Takeaways

  • Revenue changed +5.9% year-over-year
  • Net margin of 18.9%
  • P/E ratio of 24.0

Compared to other companies in the PATENT OWNERS & LESSORS sector, DLB posted revenue growth of +5.9% and trades at a P/E of 24.0.

[XNYS]

Dolby Laboratories, Inc.Class A (DLB)

$58.07

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$5439.35M
Enterprise Value
$4769.30M
P/E Ratio
24.0
Div Yield
2.48%
EV/EBITDA
14.4
Company Profile
About
About Dolby Laboratories, Inc.Class A

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

Sector

PATENT OWNERS & LESSORS

Employees

2,051

Headquarters

SAN FRANCISCO, CA

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
61
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$2592.72M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$669.39M

Cash Flow

Operating Cash Flow$437.60M
Free Cash Flow$392.67M
FCF Margin28.99%
P/FCF Ratio13.85
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$1.44

Dividend Yield

2.48%

Quarterly
Last Ex-Date: 2026-08-11

Dividend History

2026-08-11
CD$0.3600
2026-05-12
CD$0.3600
2026-02-10
CD$0.3600
2025-12-02
CD$0.3600
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.